10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,066,619 | -34.4% | 753,130 | -11.2% | 0.68% | -20.3% |
| Q2 2023 | $47,342,276 | -0.1% | 847,820 | -0.2% | 0.86% | +29.3% |
| Q1 2023 | $47,379,339 | +32.3% | 849,244 | -13.6% | 0.66% | +37.1% |
| Q4 2022 | $35,813,847 | +25.1% | 982,817 | -2.3% | 0.48% | +15.6% |
| Q3 2022 | $28,637,000 | +469.9% | 1,005,542 | +2395.1% | 0.42% | +403.6% |
| Q3 2020 | $5,025,000 | -29.7% | 40,300 | -49.6% | 0.08% | -37.6% |
| Q2 2020 | $7,145,000 | -18.1% | 80,000 | -42.9% | 0.13% | -37.3% |
| Q1 2020 | $8,725,000 | – | 140,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |